Document Detail


Do novel biomarkers add to existing scores of total cardiovascular risk?
MedLine Citation:
PMID:  22801065     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
While cardiovascular disease and certain other conditions are considered to confer a high or very high risk of cardiovascular events, the asymptomatic population can be subdivided in different categories of total CV risk using risk models; this allows the clinician to adapt the intensity of preventive strategies accordingly. Risk models, such as that based on the US Framingham Study and the SCORE model, based on European cohorts, estimate risk according to the presence of risk factors, including age, gender, smoking habits, systolic blood pressure, and cholesterol levels. However, estimation of an individual's cardiovascular risk remains approximate, and whether new biomarkers of risk will improve risk assessment is a key question. Several novel cardiovascular risk markers have been suggested, including lipid, inflammatory, thrombotic, and genetic biomarkers. Demonstrating that a novel biomarker is predictive of cardiovascular disease is, by itself, insufficient proof that it adds incremental value to existing risk estimation models. The Net Reclassification Improvement index provides an indication of the ability of a novel marker to improve risk estimation by classifying individuals to a more correct category. In addition, new risk models may be calibrated by measuring how closely predicted outcomes agree with actual outcomes. Traditional cardiovascular risk factors explain most of an individual's risk. Consequently, the addition of new risk factors to existing models has provided disappointingly small effects overall. However, there addition to conventional risk estimation may be useful in correctly reclassifying individuals at intermediate risk as above or below a chosen intervention threshold.
Authors:
Guy De Backer; Ian Graham; Marie-Therese Cooney
Related Documents :
22665105 - Hiv development assistance and adult mortality in africa.
22775275 - Onchocerciasis as a risk factor for night blindness.
22284915 - Body mass index, playing position, race, and the cardiovascular mortality of retired pr...
8702445 - Increased prevalence of systemic sclerosis in a native american tribe in oklahoma. asso...
16595425 - Young people and work injuries: an examination of jurisdictional variation within canada.
12284275 - Female condom -- new barrier device soon to be available.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of preventive cardiology     Volume:  19     ISSN:  2047-4881     ISO Abbreviation:  Eur J Prev Cardiol     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101564430     Medline TA:  Eur J Prev Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  14-7     Citation Subset:  IM    
Affiliation:
Ghent University, Ghent, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The science of risk models.
Next Document:  Assessment of subclinical atherosclerosis by carotid intima media thickness: technical issues.